Clearside Biomedical Inc (CLSD): Cormorant Reveals 10.1% Stake

Page 6 of 10

Page 6 of 10 – SEC Filing
CUSIP NO.
Item 1.
(a)
Name of Issuer
Clearside Biomedical, Inc.
(b)
Address of Issuer’s Principal Executive Offices
1220 Old Alpharetta Road, Suite 300
Alpharetta, GA 30005
Item 2.
(a)
Name of Person Filing
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LLC
Bihua Chen
(b)
Address of Principal Business Office or, if none, Residence
200 Clarendon Street, 52nd Floor
Boston, MA 02116
(c)
Citizenship
Cormorant Global Healthcare Master Fund, LP – Cayman Islands
Cormorant Global Healthcare GP, LLC – Delaware
Cormorant Asset Management, LLC – Delaware
Bihua Chen – United States
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
15063104

Follow Clearside Biomedical Inc.

Page 6 of 10